I recall conceptually Jon saying that he was looking for the FDA to consent to Neuren to be subject to the same testing standards that other pharmas are subject to for Prader Willie, as opposed to the heightened standards now applicable to Neuren, and that such a conversation not subject to any time table was to be had with the FDA. So my expectation is that the suspension may temporary pending the conduct and outcome, if favorable, of such discussions.
Ann: Update - Notification of buy-back - NEU, page-32
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.26 |
Change
-0.280(2.23%) |
Mkt cap ! $1.525B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $6.952M | 570.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 231 | $12.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.32 | 1979 | 2 |
View Market Depth
| Last trade - 16.13pm 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |